OCUPHIRE PHARMA INC's ticker is OCUP and the CUSIP is 67577R102. A total of 43 filers reported holding OCUPHIRE PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $190,280 | +74.7% | 56,800 | +126.3% | 0.00% | – |
| Q2 2023 | $108,934 | +56.6% | 25,100 | +35.3% | 0.00% | – |
| Q1 2023 | $69,548 | -59.2% | 18,546 | -61.6% | 0.00% | – |
| Q4 2022 | $170,541 | +241.1% | 48,312 | +93.2% | 0.00% | – |
| Q3 2022 | $50,000 | -41.2% | 25,000 | -43.3% | 0.00% | – |
| Q2 2022 | $85,000 | -20.6% | 44,058 | +33.5% | 0.00% | – |
| Q1 2022 | $107,000 | -43.4% | 33,000 | -35.0% | 0.00% | – |
| Q4 2021 | $189,000 | -70.3% | 50,800 | -58.9% | 0.00% | – |
| Q3 2021 | $637,000 | +749.3% | 123,702 | +767.7% | 0.00% | – |
| Q2 2021 | $75,000 | – | 14,257 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Regency Capital Management Inc.\DE | 15,000 | $79,000 | 0.06% |
| Ikarian Capital, LLC | 119,551 | $632,000 | 0.05% |
| NORRIS PERNE & FRENCH LLP/MI | 78,909 | $417,000 | 0.04% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 23,445 | $124,000 | 0.02% |
| Stokes Family Office, LLC | 12,120 | $64,000 | 0.01% |
| MARSHALL WACE, LLP | 329,131 | $1,738,000 | 0.01% |
| Cornerstone Capital, Inc. | 11,357 | $60,000 | 0.01% |
| MCF Advisors LLC | 9,499 | $50,000 | 0.01% |
| Cutler Group LLC / CA | 7,900 | $41,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 13,389 | $71,000 | 0.00% |